Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiome composition may be an indicator of preclinical Alzheimer’s disease
Aura Ferreiro, JooHee Choi, Jian Ryou, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 700
Open Access | Times Cited: 159

Showing 1-25 of 159 citing articles:

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Jian Sheng Loh, Wen Qi Mak, Li Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 237
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 135
Current understanding of the Alzheimer’s disease-associated microbiome and therapeutic strategies
Dong-oh Seo, David M. Holtzman
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 1, pp. 86-94
Open Access | Times Cited: 78
Utilization of the microbiome in personalized medicine
Karina Ratiner, Dragos Ciocan, Suhaib K. Abdeen, et al.
Nature Reviews Microbiology (2023) Vol. 22, Iss. 5, pp. 291-308
Closed Access | Times Cited: 52
Emerging role of the host microbiome in neuropsychiatric disorders: overview and future directions
Kenji Hashimoto
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3625-3637
Open Access | Times Cited: 51
Curcumin Mitigates the High-Fat High-Sugar Diet-Induced Impairment of Spatial Memory, Hepatic Metabolism, and the Alteration of the Gut Microbiome in Alzheimer’s Disease-Induced (3xTg-AD) Mice
Gopal Lamichhane, Jing Liu, Su‐Jeong Lee, et al.
Nutrients (2024) Vol. 16, Iss. 2, pp. 240-240
Open Access | Times Cited: 25
Exploring the Influence of Gut–Brain Axis Modulation on Cognitive Health: A Comprehensive Review of Prebiotics, Probiotics, and Symbiotics
Mónika Fekete, Andrea Lehoczki, Dávid Major, et al.
Nutrients (2024) Vol. 16, Iss. 6, pp. 789-789
Open Access | Times Cited: 23
Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
Yuanyuan Ma, Xin Li, Jin‐Tai Yu, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 22
Implications of microbe-derived ɣ-aminobutyric acid (GABA) in gut and brain barrier integrity and GABAergic signaling in Alzheimer’s disease
Kathryn A Conn, Emily M. Borsom, Emily K. Cope
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 17
Examining the healthy human microbiome concept
Raphaela Joos, Katy Boucher, Aonghus Lavelle, et al.
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 16
Shattering the Amyloid Illusion: The Microbial Enigma of Alzheimer’s Disease Pathogenesis—From Gut Microbiota and Viruses to Brain Biofilms
Anna Onisiforou, Eleftheria G. Charalambous, Panos Zanos
Microorganisms (2025) Vol. 13, Iss. 1, pp. 90-90
Open Access | Times Cited: 3
Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses
Puspendu Sardar, Benjamin S. Beresford-Jones, Wangmingyu Xia, et al.
Nature Microbiology (2025) Vol. 10, Iss. 3, pp. 795-807
Open Access | Times Cited: 3
Bridging gap in the treatment of Alzheimer’s disease via postbiotics: Current practices and future prospects
Bushra Bashir, Monica Gulati, Sukriti Vishwas, et al.
Ageing Research Reviews (2025), pp. 102689-102689
Closed Access | Times Cited: 2
Dietary Fiber and Microbiota Metabolite Receptors Enhance Cognition and Alleviate Disease in the 5xFAD Mouse Model of Alzheimer’s Disease
Yichen Zhou, Liang Xie, Jan Schröder, et al.
Journal of Neuroscience (2023) Vol. 43, Iss. 37, pp. 6460-6475
Open Access | Times Cited: 28
Gut microbiota-host lipid crosstalk in Alzheimer’s disease: implications for disease progression and therapeutics
Yaxi Luo, Ling-Ling Yang, Xiu‐Qing Yao
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 14
Alzheimer’s Disease: Models and Molecular Mechanisms Informing Disease and Treatments
Kaden Nystuen, Shannon M. McNamee, Monica Akula, et al.
Bioengineering (2024) Vol. 11, Iss. 1, pp. 45-45
Open Access | Times Cited: 13
Update on modifiable risk factors for Alzheimer's disease and related dementias
Methasit Jaisa-aad, Clara Muñoz‐Castro, Alberto Serrano‐Pozo
Current Opinion in Neurology (2024) Vol. 37, Iss. 2, pp. 166-181
Open Access | Times Cited: 11
Kai-xin-san improves cognitive impairment in D-gal and Aβ25-35 induced ad rats by regulating gut microbiota and reducing neuronal damage
Huijuan Wang, Lifen Zhou, Zheng Qin, et al.
Journal of Ethnopharmacology (2024) Vol. 329, pp. 118161-118161
Closed Access | Times Cited: 11
Do microbes play a role in Alzheimer's disease?
Zoë Williams, Léonie Láng, Sarah Nicolas, et al.
Microbial Biotechnology (2024) Vol. 17, Iss. 4
Open Access | Times Cited: 10
The link between gut microbiome and Alzheimer's disease: From the perspective of new revised criteria for diagnosis and staging of Alzheimer's disease
Yuan Liang, Congcong Liu, Manman Cheng, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 8, pp. 5771-5788
Open Access | Times Cited: 10
The microbiota-gut-brain-immune interface in the pathogenesis of neuroinflammatory diseases: a narrative review of the emerging literature
Alison Warren, Yvonne Nyavor, Nikkia Zarabian, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
How Do Microbial Metabolites Interact with Their Protein Targets?
Mario Astigarraga, Andrés Sánchez-Ruiz, Aminata Diop-Aw, et al.
Journal of Chemical Information and Modeling (2025) Vol. 65, Iss. 1, pp. 201-213
Closed Access | Times Cited: 1
Ultra-processed food consumption and risk of dementia and Alzheimer's disease: The Framingham Heart Study
Galit Weinstein, Daniel Kojis, A Banerjee, et al.
The Journal of Prevention of Alzheimer s Disease (2025) Vol. 12, Iss. 2, pp. 100042-100042
Open Access | Times Cited: 1
How the gut microbiota impacts neurodegenerative diseases by modulating CNS immune cells
Philipp Schaible, Julia Henschel, Daniel Erny
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Microbial underdogs: exploring the significance of low-abundance commensals in host-microbe interactions
Geongoo Han, Shipra Vaishnava
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 12, pp. 2498-2507
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top